Today@UCI Home University of California, Irvine is a top-ranked university dedicated to research, scholarship and community service
 
   Search Tips   
Saturday, September 20, 2014 | Contact University Communications | UCI Home
Home
Calendar
Newsroom
• Zot!Wire
• Press Releases
• Tipsheets
• Experts
• UCI in the News
• Healthcare News
Special Reports & Spotlights
• Arts & Humanities
• Campus Life
• Education
• Environment & Energy
• Health & Medicine
• Science & Business
• Society & Culture
Quick Facts
• Economic Impact
• Distinctions
• Fact Sheets
• Statistics & Reports
Resources
• Publications
• Graphic Identity
• Style Guide
• Meet the Media
Chancellor's Site
Emergency Readiness
Home > News > Press Releases & Media Advisories > Press Release

Hans Keirstead to brief Congress on stem cell research


UCI scientist is behind the field’s first human clinical trial


Irvine, Calif., March 23, 2009

UC Irvine’s Hans Keirstead – the neurobiologist behind what will be the world’s first human embryonic stem cell clinical trial – will brief Congress on the state of the field 10-11:30 a.m. Tuesday, March 24, in Washington, D.C.

Keirstead will join Robert Klein, a spinal-cord-injury research advocate, and Thomas Okarma, Geron Corp. president and chief executive officer, for the briefing, in Room H-122 of the Capitol. Geron will conduct the clinical trial for Keirstead’s acute-spinal-cord-injury therapy.

Keirstead will discuss that treatment, recently approved for human clinical testing by the U.S. Food and Drug Administration, and other stem cell therapies in development. He also will stress the need for collaboration between academia and industry.

“This union is critical to moving new therapies from the laboratory to the clinic,” said Keirstead, co-director of UCI’s Sue and Bill Gross Stem Cell Research Center and faculty member at the Reeve-Irvine Research Center, which seeks new treatments for spinal-cord injuries. In addition, Keirstead plans to meet one-on-one with policy- and lawmakers during his trip.

Former Rep. James C. Greenwood, R-Pa., will moderate the briefing, titled “Expanding Stem Cell Research: Finding Cures and Changing Lives.” Greenwood is president and chief executive officer of the Biotechnology Industry Organization, the world’s largest biotechnology group.

Earlier this month, President Obama lifted federal funding restrictions on human embryonic stem cell research, clearing the way for additional money to flow to this fast-growing field, which one day could produce a treatment or cure for people with cancer, diabetes, Alzheimer’s or Parkinson’s disease, or other life-threatening disorders.


About the University of California, Irvine: UCI is a top-ranked university dedicated to research, scholarship and community service. Founded in 1965, UCI is among the fastest-growing University of California campuses, with more than 27,000 undergraduate and graduate students, 1,100 faculty and 9,200 staff. The top employer in dynamic Orange County, UCI contributes an annual economic impact of $4.2 billion. For more UCI news, visit www.today.uci.edu.

News Radio: UCI maintains on campus an ISDN line for conducting interviews with its faculty and experts. Use of this line is available for a fee to radio news programs/stations that wish to interview UCI faculty and experts. Use of the ISDN line is subject to availability and approval by the university.


Hans Keirstead. Photo by Daniel A. Anderson. Hans Keirstead. Photo by Daniel A. Anderson.

Related Links

Contact

Jennifer Fitzenberger
949-824-3969
jfitzen@uci.edu

Archives

Aug. 2014
July 2014
June 2014
May 2014
April 2014
March 2014
Feb. 2014
Jan. 2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
UCI Home
A Service of University Communications © Copyright 2002-2009 UC Regents